SAN CARLOS, Calif., Apr 04, 2007 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) announced today that its corporate presentation will be webcast live by CIBC World Markets at its Annual Biotechnology & Specialty Pharmaceuticals Conference in New York on Wednesday, April 11, 2007 beginning at 11:30am (Eastern Time). The presentation by senior management may be accessed live on the investor relations' page at www.nektar.com and will be available until April 25, 2007.
Nektar Therapeutics is a biopharmaceutical company with a mission to develop and enable differentiated therapeutics with its industry-leading pulmonary and PEGylation technology platforms. Nektar pulmonary and PEGylation technology, expertise, manufacturing capabilities and know-how have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its pulmonary and PEGylation technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Tim Warner, 650-283-4915 twarner@nektar.com Stephan Herrera, 415-488-7699 sherrera@nektar.com
Copyright Business Wire 2007
News Provided by COMTEX